Delivery Order SPE2DB20D1004-SPE2DB20FF1B2
- Not listed
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,940.60 delivery order was issued by the Defense Logistics Agency (DLA) and has a firm fixed price. The contract supports the DLA Troop Support Medical program, providing a range of pharmaceutical products, medical devices, and other healthcare commodities to military treatment facilities and veterans' healthcare programs....
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $19,874.96 delivery order was issued by the Defense Logistics Agency (DLA) and has a firm fixed price. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for the company to deliver a...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,680.51 delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of May 21, 2021. The contract is a firm-fixed-price delivery order and does not have any set-aside designations, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,228.70 awarded by the Defense Logistics Agency (DLA). The contract is for pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,481.50 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order valued at $50,133.85 for the supply of pharmaceutical products and medical supplies to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract has no set-aside designation and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,366.37 delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of September 28, 2020. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,318.85 for pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 15, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $29,092.94 delivery order was issued by the Defense Logistics Agency (DLA) and has a performance period through March 2021. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies to support the U.S. government's healthcare needs. The $1,434.10 delivery order contract is with the Defense Logistics Agency (DLA) Troop Support Medical, a major customer for Amerisourcebergen. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2025, which serves as...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB20FF1B2Delivery Order
This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,339.41 delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 2, 2020. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. In addition, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 9/11/20 |